Amanda Guitián-Caamaño
@amandaguitian.bsky.social
Postdoctoral fellow at Freeman’s lab📍UCD, Conway 🇮🇪
🔬 #Osteosarcoma #OrganOnAChip #3DBioprinting #Immunotherapy #3DModels
https://www.ucd.ie/freemanlab
🔬 #Osteosarcoma #OrganOnAChip #3DBioprinting #Immunotherapy #3DModels
https://www.ucd.ie/freemanlab
🚨 Finally out! 🚨
I’m thrilled to share that one of the papers from my doctoral thesis is now officially published in Nature Comms!
Even more exciting — it’s my first paper as a co–first author! 👩🏻🔬👩🏻💻
Huge thanks to everyone who supported us throughout this journey 🙌
🔗 www.nature.com/articles/s41...
I’m thrilled to share that one of the papers from my doctoral thesis is now officially published in Nature Comms!
Even more exciting — it’s my first paper as a co–first author! 👩🏻🔬👩🏻💻
Huge thanks to everyone who supported us throughout this journey 🙌
🔗 www.nature.com/articles/s41...
Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity - Nature Communications
Drug resistance remains a major challenge in cancer treatment. Here, the authors identify Connexin43 as target that enhances BRAF/MEKi efficacy by interfering with DNA repair pathways, overcoming drug...
www.nature.com
July 5, 2025 at 12:15 PM
🚨 Finally out! 🚨
I’m thrilled to share that one of the papers from my doctoral thesis is now officially published in Nature Comms!
Even more exciting — it’s my first paper as a co–first author! 👩🏻🔬👩🏻💻
Huge thanks to everyone who supported us throughout this journey 🙌
🔗 www.nature.com/articles/s41...
I’m thrilled to share that one of the papers from my doctoral thesis is now officially published in Nature Comms!
Even more exciting — it’s my first paper as a co–first author! 👩🏻🔬👩🏻💻
Huge thanks to everyone who supported us throughout this journey 🙌
🔗 www.nature.com/articles/s41...
Today our Phd student Erick Solorio has presented his great latest results on the development of a new #organ-on-a-chip device in #osteosarcoma at the 2025 Workshop on Standardisation of Micro fluidic Devices.
Congratulations Erick! 🙌🏼🎉
#FreemanLab
Congratulations Erick! 🙌🏼🎉
#FreemanLab
March 21, 2025 at 2:25 PM
Today our Phd student Erick Solorio has presented his great latest results on the development of a new #organ-on-a-chip device in #osteosarcoma at the 2025 Workshop on Standardisation of Micro fluidic Devices.
Congratulations Erick! 🙌🏼🎉
#FreemanLab
Congratulations Erick! 🙌🏼🎉
#FreemanLab
Today, on International #ChildhoodCancerDay, we at Freeman Group reaffirm our commitment to the fight against osteosarcoma, a cancer that mainly affects children and adolescents. We are hard working to learn more about this rare disease and to improve its treatment 💡
#ScienceSavesLives #Osteosarcoma
#ScienceSavesLives #Osteosarcoma
February 15, 2025 at 10:03 AM
Today, on International #ChildhoodCancerDay, we at Freeman Group reaffirm our commitment to the fight against osteosarcoma, a cancer that mainly affects children and adolescents. We are hard working to learn more about this rare disease and to improve its treatment 💡
#ScienceSavesLives #Osteosarcoma
#ScienceSavesLives #Osteosarcoma